Blood markers in early pregnancy and pregnancy outcomes
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This trial is checking if certain proteins in your blood (called placental growth factor and nucleosomes) during early pregnancy can help predict problems like preeclampsia or preterm birth. If you join, you'll give a blood sample during your regular NIPT test, and researchers will follow your pregnancy to see how it goes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant with one baby (not twins or more).
- You will have a Non-Invasive Prenatal Test (NIPT) — a simple blood test — between 12 and 14 weeks of pregnancy.
- You plan to give birth at the Second Affiliated Hospital of Wenzhou Medical University.
- You are between 18 and 39 years old and have a body mass index (BMI) between 18.5 and 29.9.
- You do not have certain long-term health issues (like high blood pressure, diabetes, or autoimmune disease) and you do not smoke or drink heavily.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a blood test done early in pregnancy (NIPT) to see if it can help predict conditions like preeclampsia, preterm labor, or gestational diabetes. If you had this test and had a healthy pregnancy or one of these complications, you may be able to join.
This trial tests whether measuring two pregnancy blood markers (sFlt1 and PlGF) and planning delivery timing can help prevent preeclampsia as you reach term. It may help reduce risk for mother and baby by guiding when to deliver based on test results.
This study tests a new blood test to track how the body responds to treatment during pregnancy, especially for those at risk of high blood pressure conditions. It may help doctors monitor and improve care.
This study tests if certain blood markers can help diagnose and monitor preeclampsia. It aims to improve how this serious pregnancy condition is detected and treated.
This study looks at the placenta and the area where the baby meets the mother's body to understand preeclampsia, a serious pregnancy complication. If you are between 9 and 15 weeks pregnant with one baby and are already scheduled for a placenta test, you may be able to join.
This study looks at two ways to manage early-onset fetal growth restriction (when a baby is smaller than expected). It compares using blood tests for angiogenic factors versus feto-placental Doppler ultrasound to guide care. The goal is to find the best way to monitor and protect your baby's health.
Hear when a new Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.